SEPTERNA

Our mission is to discover, develop, and commercialize medicines that improve the lives of patients by combining the potential of high-value GPCR drug targets with the power of state-of-the-art small molecule drug discovery technologies. Septerna's Native Complex Platform™ is the engine that will make this happen, moving ideas for disease-modifying therapies from possibility to reality... As Septerna crystallized, our team of scientists and drug hunters took on the challenge of making the Native Complex Platform™ a reality by building an industrialized platform from the ground up, capable of isolating and controlling GPCRs in a revolutionary new way for drug discovery. We continue to create our story - advancing our first small molecule drug discovery programs on the way to creating meaningful future medicines for patients... We are focusing the Native Complex Platform™ on tackling previously difficult-to-drug GPCR targets, and our small molecule drug discovery efforts have rapidly..

Primary location: South San Francisco United States